Prof. G.M. van Dam, MD, PhD

Prof. G.M. van Dam, MD, PhD

A pioneer in the optical imaging field with groundbreaking research to his name. Co-founder Prof. Van Dam, surgeon oncologist and professor of Surgery at Groningen University, trained at Harvard, the Mayo Clinic, and NCI. He has published the 1st in-human application of targeted fluorescence imaging in 2011 (Nature Medicine) and published more than 140 papers predominantly on the subject of clinical translation of innovative targeted optical molecular imaging. More recently, he has published on the importance of standardization for validation of clinical fluorescent imaging studies towards an industrial standard.

Blog

FDA Accelerated Approval Program

Prof. G.M. van Dam, MD, PhD
Blog

Molecular imaging in gene therapy

Prof. G.M. van Dam, MD, PhD
Blog

How to get your first-in-human trial approved in The Netherlands

Prof. G.M. van Dam, MD, PhD
Blog

The FDA Fast Track program: the ins and outs

Prof. G.M. van Dam, MD, PhD
Blog

Molecular imaging as a blueprint for patient stratification

Prof. G.M. van Dam, MD, PhD
Blog

How to design your first-in-human study: patient and tracer selection

Prof. G.M. van Dam, MD, PhD
Blog

Four reasons to conduct your clinical trial in The Netherlands

Prof. G.M. van Dam, MD, PhD
Blog

The latest developments in fluorescence imaging

Prof. G.M. van Dam, MD, PhD
Blog

Radiopharmaceuticals are on the rise as drug developers realize enormous potential

Prof. G.M. van Dam, MD, PhD
Blog

How to determine clinical endpoints for fluorescence-guided surgery

Prof. G.M. van Dam, MD, PhD
Blog

How does cardiovascular imaging work?

Prof. G.M. van Dam, MD, PhD
Blog

How to generate in-human data on antibodies with microdosing

Prof. G.M. van Dam, MD, PhD
Blog

Hitting the R&D sweet spot with fast in-human studies

Prof. G.M. van Dam, MD, PhD
Blog

5 must read articles that changed the molecular imaging space

Prof. G.M. van Dam, MD, PhD
Blog

What are clinical molecular imaging studies?

Prof. G.M. van Dam, MD, PhD
Blog

The use of nuclear and optical molecular imaging in drug development

Prof. G.M. van Dam, MD, PhD
Blog

How to transform your compound into in-human data in five steps

Prof. G.M. van Dam, MD, PhD
Blog

In-Human Microdosing

Prof. G.M. van Dam, MD, PhD